DAX Street
  • Home
  • Cars
  • News
  • Tech
No Result
View All Result
  • Home
  • Cars
  • News
  • Tech
No Result
View All Result
DAX Street
No Result
View All Result
Home News

President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir

Jayson O'Neil by Jayson O'Neil
October 4, 2020
in News
0
President had stakes in Regeneron and Gilead, makers of antibody cocktail, Remdesivir

President Donald Trump previously reported he earned capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the manufacturers of two of the medicines he’s taken as part of his COVID-19 treatment plan.

According to a 2017 financial disclosure form filed with the U.S. Office of Government Ethics in June 2017, Trump had a capital gain of $50,001 to $100,000 for Regeneron Pharmaceuticals and $100,001 to $1 million for Gilead Sciences Inc. The form notes the information was of April 15, 2017.

Trump’s subsequent disclosure forms, including his 2020 form signed July 31, did not list Regeneron or Gilead.

Trump received a single 8-gram dose of Regeneron’s polyclonal antibody cocktail as a precautionary measure, according to his physician Sean Conley. The antibody cocktail is in four late-stage clinical trials, and its safety and efficacy have not been fully evaluated by any regulatory authority, the company said on its webpage. As part of Operation Warp Speed, New York state-based Regeneron won a $450 million federal contract in July to manufacture and supply the company’s antibody cocktail REGN-COV2.

The New York Times reported Friday that Regeneron’s chief executive, Dr. Leonard S. Schleifer, a member of Trump’s golf club in Westchester County, New York, said Trump’s medical staff reached out to the company for permission to use the drug and the Food and Drug Administration cleared it. “All we can say is that they asked to be able to use it, and we were happy to oblige,” Schleifer told the Times, calling it a “compassionate use” case. Trump isn’t the first patient to try the experimental treatment outside of the clinical trial through compassion use. “When it’s the president of the United States, of course, that gets – obviously – gets our attention,” Schleifer told the Times. Regeneron stock rose $19.20 a share in after-hours trading.

Trump also is taking Gilead’s remdesivir, which has been authorized for COVID-19 patients by the FDA under an emergency use declaration. Trials showed effectiveness under some circumstances.

Remdesivir received a guarded endorsement in April from Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, when it was announced as a new tool in the fight against the virus at a presidential new conference.

Previous Post

Can the stock market predict whether Joe Biden will be the next president or Donald Trump wins a second term?

Next Post

Takata recall: Exploding air bag inflator in Honda Civic kills Arizona driver, bring the worldwide death toll to 26

Jayson O'Neil

Jayson O'Neil

Jayson is a car-o-holic, and you will often find him writing about cars & bikes here at DaxStreet. You can reach out to him at Jay@daxstreet.com

Next Post
Takata recall: Exploding air bag inflator in Honda Civic kills Arizona driver, bring the worldwide death toll to 26

Takata recall: Exploding air bag inflator in Honda Civic kills Arizona driver, bring the worldwide death toll to 26

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Recent Posts

  • 2021 Lexus IS or 2021 BMW 3 Series: Pros and Cons Review
  • NFDA urges Government to extend COVID-19 business support in 2021 Budget
  • ICDP identifies 25% return on sales with ‘clean slate’ car distribution model
  • Consumer new car finance volumes declined 25% in 2020, FLA reports
  • Isuzu UK names David Taylor Garages as its Dealer of the Year
  • About Us
  • Contact Us
  • RSS Feed
  • Verification and Fact-Checking Policy
  • Privacy Policy
  • Reader Engagement & Feedback Policy
  • Terms Of Service
  • Ownership & Funding Information
  • Ethics Policy & Mission
  • Editorial Policy
  • DMCA
  • Diversity & Corrections Policy
  • Disclaimer
  • Cookie Policy

© 2021 DaxStreet All Rights Resrerved.

No Result
View All Result
  • Home
  • Cars
  • News
  • Tech

© 2021 DaxStreet All Rights Resrerved.